AAV-based gene therapy with modified HEXB confers lasting therapeutic benefits in GM2 gangliosidosis models. (linkinghub.elsevier.com)

Authors: Kitakaze K … Itoh K Journal: Cell Reports Medicine Published: 2026-05-19 DOI: https://doi.org/10.1016/j.xcrm.2026.102762